Previous product
Back to products
Ninlaro (ixazomib)
CHF7,150.00
Next product
Opdivo (Nivolumab)
CHF624.00
Tecentriq (Atezolizumab)
CHF5,125.77
Tecentriq (atezolizumab) is a medication used for the treatment of locally advanced or metastatic urothelial carcinoma, for the treatment of metastatic non-small cell lung cancer (NSCLC), and for the treatment of advanced triple negative breast cancer (TNBC).
Reviews
There are no reviews yet.